Elzerbi Catherine, Donoghue Kim, Drummond Colin
National Addiction Centre, Addictions Department, King's College London, London, UK.
Addiction. 2015 Jul;110(7):1082-91. doi: 10.1111/add.12960.
The extent of variation attributable to regional differences for the efficacy of brief intervention (BI) to reduce hazardous and harmful alcohol consumption is unclear. The primary aim of this study was to determine overall efficacy of BI at 6- and 12-month follow-up in primary health care (PHC) and emergency department (ED) studies. The secondary aim was to examine whether variance in study outcome can be explained by the geographical region in which trials have taken place (European versus non-European).
A systematic review and meta-analysis of randomized controlled trials (RCTs) published before August 2014 was undertaken. Twenty RCTs conducted in PHC settings with a total of 8226 participants (European = 4564/non-European = 3662) and eight RCTs conducted in ED settings with a total of 4799 participants (European = 2465/non-European = 2334) were eligible. Primary outcome measure was reduction in grams of alcohol consumed per week for BI and control groups at 6- and 12-month follow-up. An inverse variance model was applied to measure the effect of treatment in mean differences for BI and control groups at 6- and 12-month follow-up. Variance between study outcomes was explored using subgroup analysis of European versus non-European countries.
For PHC trials at 6-month follow-up, statistically significant benefits of BI were indicated [mean difference (MD) = -21.98 g/week; 95% confidence interval (CI) = -37.40 to -6.57; P = 0.005]. At 12-month follow-up, statistically significant benefit of BI was evident (MD = -30.86 g/week; 95% CI = -46.49 to -15.23; P = 0.0001). For ED trials at 6-month follow-up, statistically significant benefits of BI were indicated (MD = -17.97 g/week; 95% CI = -29.69 to -6.24; P = .003). At 12-month follow-up, statistically significant benefit in favour of BI was evident (MD = -18.21 g/week; 95% CI = -26.71 to -9.70; P < 0.0001). No statistically significant differences were detected in subgroup analyses of outcomes for European versus non-European studies.
Brief intervention (BI) to reduce alcohol consumption is associated with reducing grams of alcohol consumed per week among hazardous and harmful drinkers at 6- and 12-month follow-up in primary health care and emergency department trials. The geographical region in which trials are undertaken does not appear to explain the variance in trial outcomes for reducing alcohol consumption.
简短干预(BI)减少危险及有害饮酒行为的疗效中,可归因于地区差异的变化程度尚不清楚。本研究的主要目的是确定在初级卫生保健(PHC)和急诊科(ED)研究中,随访6个月和12个月时BI的总体疗效。次要目的是检验研究结果的差异是否可由试验开展的地理区域(欧洲与非欧洲)来解释。
对2014年8月之前发表的随机对照试验(RCT)进行系统综述和荟萃分析。在PHC环境中进行的20项RCT符合条件,共有8226名参与者(欧洲 = 4564名/非欧洲 = 3662名);在ED环境中进行的8项RCT符合条件,共有4799名参与者(欧洲 = 2465名/非欧洲 = 2334名)。主要结局指标是随访6个月和12个月时,BI组和对照组每周饮酒克数的减少量。应用逆方差模型来测量随访6个月和12个月时,BI组和对照组平均差异的治疗效果。通过欧洲与非欧洲国家的亚组分析来探讨研究结果之间的差异。
对于PHC试验,随访6个月时,BI显示出具有统计学意义的益处[平均差异(MD)=-21.98克/周;95%置信区间(CI)=-37.40至-6.57;P = 0.005]。随访12个月时,BI的益处具有统计学意义(MD = -30.86克/周;95% CI = -46.49至-15.23;P = 0.0001)。对于ED试验,随访6个月时,BI显示出具有统计学意义的益处(MD = -17.97克/周;95% CI = -29.69至-6.24;P = 0.003)。随访12个月时,支持BI的益处具有统计学意义(MD = -18.21克/周;95% CI = -26.71至-9.70;P < 0.0001)。在欧洲与非欧洲研究的结局亚组分析中,未检测到统计学上的显著差异。
在初级卫生保健和急诊科试验中,随访6个月和12个月时,减少饮酒量的简短干预(BI)与减少危险及有害饮酒者每周饮酒克数相关。试验开展的地理区域似乎并不能解释减少饮酒量试验结果的差异。